Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Nasojejunal versus oral feeding after endoscopic drainage of walled-off pancreatic necrosis

Official title: Nasojejunal Feeding Versus Oral Feeding Following Endoscopic Drainage of Walled Off Pancreatic Necrosis: A Randomized Controlled Pilot Study

Run by Post Graduate Institute of Medical Education and Research, Chandigarh · NCT07395778 · Data updated 2026-11-12

This will see if feeding through a tube into the small intestine (nasojejunal feeding) works better than eating by mouth for adults undergoing endoscopic drainage of walled-off pancreatic necrosis.

More Acute Pancreatitis (AP) trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment50 (estimated)
SponsorPost Graduate Institute of Medical Education and Research, Chandigarh
Academic / other
Locations1 site (Chandigarh)
StatusRecruiting
StartedOctober 18, 2025
Main results expectedDecember 31, 2026
Study endsJanuary 2027
Registry record updatedFebruary 9, 2026
Trial IDNCT07395778 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–75 with symptomatic walled-off pancreatic necrosis who require EUS-guided transluminal drainage and can give informed consent are the intended participants.

Probably not a fit

Patients whose collections are not reachable by EUS, those with active GI bleeding or obstruction, major immunosuppression or malignancy, prior disruptive upper GI surgery, severe coagulopathy, pregnancy/lactation, or those too unstable for endoscopy are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center randomized trial at PGIMER Chandigarh compares nasojejunal tube feeding to oral feeding following endoscopic ultrasonography-guided cystogastrostomy for symptomatic walled-off pancreatic necrosis. Adult patients (18–75 years) who require EUS-guided transluminal drainage and can consent are randomized to one of the two nutritional strategies after the procedure. Key outcomes include infection rates, tube/feed tolerance, weight change, and need for reintervention. Patients with collections not amenable to EUS drainage, major comorbidities, active GI bleeding or obstruction, severe coagulopathy, pregnancy/lactation, or those who are moribund are excluded.

Why it matters

Potential benefit: If successful, the trial could identify a feeding approach that reduces infections and improves nutritional recovery after endoscopic drainage of walled-off pancreatic necrosis.

How similar studies have gone: Nasojejunal feeding has been used in severe acute pancreatitis and has supportive observational data, but direct randomized evidence specifically comparing nasojejunal versus oral feeding after endoscopic drainage of WON is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients of acute pancreatitis (AP) with 18-75 years of age
2. Patients with symptomatic WON requiring EUS guided transluminal drainage
3. Provision of written informed consent

Exclusion Criteria:

1. Patients with collection not amenable for EUS guided drainage (distance of WON \>1 cm from the gastrointestinal lumen)
2. Known malignancy or immunocompromised state
3. Previous upper gastrointestinal(GI) surgery interfering with absorption
4. Active GI bleeding
5. GI obstruction, ileus or persistent vomiting
6. Patients moribund to undergo endoscopic procedure (Glasgow coma scale \<8 or patients on ventilatory support)
7. Patients with irreversible coagulopathy like platelets \<50,000/mm3 and/or INR\>1.5
8. Pregnant or lactating female

Where it's running

  • Post Graduate Institute of Medical Education and Research (PGIMER)
    Chandigarh, India
    Recruiting

Study contacts

  • Principal investigator: Surender Singh Rana, Professor — Post Graduate Institute of Medical Education and Research, Chandigarh
  • Study coordinator: Saurabh Kumar Singh
  • Email: drsaurabhkrsingh@gmail.com
  • Phone: +919560113930

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.